https://patentbrief.org/company/nbe-therapeutics-ag Plain-English explanations of patents assigned to NBE Therapeutics AG, newest first. en-us Sun, 12 Jul 2026 09:30:29 GMT https://patentbrief.org/patent/us/12121527/anthracycline-based-antibody-drug-conjugates-having-high-in-vivo-tolerability This patent describes a specific way to build antibody-drug conjugates (ADCs) for cancer treatment by precisely attaching chemotherapy drugs to antibodies to make them safer inside the body. Tue, 22 Oct 2024 00:00:00 GMT https://patentbrief.org/patent/us/12121527/anthracycline-based-antibody-drug-conjugates-having-high-in-vivo-tolerability